[1] DENT R, TRUDEAU M, PRITCHAED K I, et al. Triple-negative breast cancer: clinical features and patterns of recurrence[J]. Clin Cancer Res, 2007, 13(15 Pt 1):4429-4434. [2] YU X, ZHANG Z, WANG Z, et al. Prognostic and predictive value of tumor-infiltrating lymphocytes in breast cancer: A systematic review and meta-analysis[J]. Clin Transl Oncol, 2016, 18(5):497-506. [3] 杨志, 李宁, 廖光星,等. 乳腺癌原发灶弥散加权成像在预测腋窝淋巴结转移中的应用价值[J]. 郑州大学学报:医学版, 2017, 52(4):448-451. [4] 王正想,刘思源. 基因沉默治疗恶性肿瘤的研究进展[J]. 河北医科大学学报, 2017, 38(8):988-992. [5] JAIN A K, ALLTON K, DUNCAN A D, et al. TRIM24 is a p53-induced E3-ubiquitin ligase that undergoes ATM-mediated phosphorylation and autodegradation during DNA damage[J]. Mol Cell Biol, 2014, 34(14):2695-2709. [6] MIAO Z F, WANG Z N, ZHAO T T, et al. TRIM24 is upregulated in human gastric cancer and promotes gastric cancer cell growth and chemoresistance[J]. Virchows Arch, 2015, 466(5):525-532. [7] LIU X, HUANG Y, YANG DH, et al. Overexpression of TRIM24 is associated with the onset and progress of human hepatocellular carcinoma[J]. PLoS One, 2014, 9(1):e85462. [8] 严泓, 周竹超. TRIM24在乳腺癌组织中的表达与患者淋巴节转移的相关性[J]. 临床与病理杂志, 2018, 38(2):267-275. [9] SARAF A, GRUBB C S, HWANG M E, et al. Breast cancer subtype and stage are prognostic of time from breast cancer diagnosis to brain metastasis development[J]. J Neurooncol, 2017, 134(2):453-463. [10] 魏薇, 张增梅, 赵海运, 等. 射线防护在术中放疗联合乳腺癌保乳术中应用效果观察[J]. 郑州大学学报:医学版, 2018, 53(5):136-139. [11] 黄耀孟, 吴珺,李秉慧. miRNA在乳腺癌诊断、预后和预测中的应用[J]. 河北医科大学学报, 2018, 39(9):114-120. [12] ALLTON K, JAIN A K, HERZ H M, et al. Trim24 targets endogenous p53 for degradation[J]. Proc Natl Acad Sci U S A, 2009, 106(28):11612-11616. [13] THAKKAR K N, STRATTON S A, CRAIG BARTON M. Tissue-specific metabolism and TRIM24[J]. Aging(Albany NY), 2015, 7(10):736-737. [14] MA L, YUAN L L, AN J, et al. Histone H3 lysine 23 acetylation is associated with oncogene TRIM24 expression and a poor prognosis in breast cancer[J]. Tumour Biol, 2016, 37(11):14803-14812. [15] CHI J, YANG Q, XIE X F, et al. Clinical significance and prognostic value of TRIM24 expression in esophageal squamous cell carcinoma[J]. Aging(Albany NY), 2016, 8(9):2204-2221. [16] GRONER A C, CATO L, DE TRIBOLET-HARDY J, et al. TRIM24 is an oncogenic transcriptional activator in prostate cancer[J]. Cancer Cell, 2016, 29(6):846-858. [17] LI H Y, SUN L L, TANG Z P, et al. Overexpression of TRIM24 correlates with tumor progression in non-small cell lung cancer[J]. PLoS One, 2012, 7(5):e37657. [18] FANG Z, DENG J, ZHANG L, et al. TRIM24 promotes the aggression of gastric cancer via the Wnt/β-catenin signaling pathway[J]. Oncol Lett, 2017, 13(3):1797-1806. [19] LIN L, ZHAO W H, SUN B, et al. Overexpression of TRIM24 is correlated with the progression of human cervical cancer[J]. Am J Transl Res, 2017, 9(2):620-628. [20] WANG J W, ZHU J H, DONG M J, et al. Knockdown of tripartite motif containing 24 by lentivirus suppresses cell growth and induces apoptosis in human colorectal cancer cells[J]. Oncol Res, 2014, 22(1):39-45. |